<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Nanjing Clasien Pharmaceutical %26 Chemical Co.%2C Ltd. from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Nanjing Clasien Pharmaceutical %26 Chemical Co.%2C Ltd. news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 23:25:25 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Nanjing+Clasien+Pharmaceutical+%26+Chemical+Co.%2C+Ltd." rel="self" type="application/rss+xml" />

	
<item><title>Orbus Pharma Inc. Announces Progress on its Private Placement with Nanjing Sanhome Pharmaceutical Co., Ltd</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025438&amp;HITNO=0&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025438&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529767932%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025438&amp;HITNO=0&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025438&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529767932%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Filing Services Canada:</description></item>
<item><title>Orbus Pharma Inc. Announces Progress on its Private Placement with Nanjing Sanhome Pharmaceutical Co., Ltd.</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4021530&amp;HITNO=1&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4021530&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527253188%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4021530&amp;HITNO=1&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4021530&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527253188%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Orbus Pharma Inc. Announces Progress on its Private Placement with Nanjing Sanhome Pharmaceutical Co., Ltd.</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4020897&amp;HITNO=2&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4020897&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527052608%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4020897&amp;HITNO=2&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4020897&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527052608%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Chongqing Chemical Pharmaceutical Holding (Group) Co. to sell RMB...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002524&amp;HITNO=3&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002524&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519029541%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002524&amp;HITNO=3&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002524&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519029541%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>Suzhou Eyre cleared for penicillin production by SFDA</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002125&amp;HITNO=4&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002125&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518745570%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002125&amp;HITNO=4&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002125&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518745570%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>In-Pharmatechnologist:</description></item>
<item><title>Changda International Holdings, Inc. (CIHD-OTC-BB) Appointed by the Provincial Government of Shandong, China as Founder of an R&amp;D Center for Pharmaceutical Building Blocks Used in the Production of Cardiovascular Medication</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970552&amp;HITNO=5&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970552&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501384967%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970552&amp;HITNO=5&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970552&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501384967%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Changda International Holdings, Inc. (CIHD-OTC-BB) Appointed by the Provincial Government of Shandong, China as Founder of an R&amp;D Center for Pharmaceutical Building Blocks Used in the Production of Cardiovascular Medication</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970508&amp;HITNO=6&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970508&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501354403%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970508&amp;HITNO=6&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970508&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501354403%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire via Yahoo!:</description></item>
<item><title>Changda International Holdings, Inc. (CIHD-OTC-BB) Appointed by the Provincial Government of Shandong, China as Founder of an R&amp;D Center for Pharmaceutical Building Blocks Used in the Production of Cardiovascular Medication</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970474&amp;HITNO=7&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970474&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501342200%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970474&amp;HITNO=7&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970474&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501342200%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>Changda International Holdings, Inc. (CIHD-OTC-BB) Appointed by the Provincial Government of Shandong, China as Founder of an R&amp;D Center for Pharmaceutical Building Blocks Used in the Production o</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970458&amp;HITNO=8&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970458&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501327206%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970458&amp;HITNO=8&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970458&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501327206%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Changda International Holdings, Inc. (CIHD-OTC-BB) Appointed by the Provincial Government of Shandong, China as Founder of an R&amp;D Center for Pharmaceutical Building Blocks Used in the Production of Cardiovascular Medication</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970417&amp;HITNO=9&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970417&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501318150%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970417&amp;HITNO=9&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970417&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501318150%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Stockwatch:</description></item>
<item><title>Changda International Holdings, Inc. (CIHD-OTC-BB) Appointed by the Provincial Government of Shandong, China as Founder of an R&amp;D Center for Pharmaceutical Building Blocks Used in the Production of Cardiovascular Medication</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970363&amp;HITNO=10&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970363&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501297539%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970363&amp;HITNO=10&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970363&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501297539%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FinanzNachrichten.de:</description></item>
<item><title>Changda International Holdings, Inc. (CIHD-OTC-BB) Appointed by the Provincial Government of Shandong, China as Founder of an R&amp;D Center for Pharmaceutical Building Blocks Used in the Production of Cardiovascular Medication</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970362&amp;HITNO=11&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970362&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501297534%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3970362&amp;HITNO=11&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3970362&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2501297534%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FinanzNachrichten.de:</description></item>
<item><title>Midlands based Sterling Pharmaceuticals forging ahead</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3958291&amp;HITNO=12&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3958291&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2495310767%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3958291&amp;HITNO=12&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3958291&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2495310767%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MidlandsBusinessNews.co.uk:</description></item>
<item><title>Cervical Cancer - Reports outline cervical cancer study findings from China Pharmaceutical University</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3952675&amp;HITNO=13&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3952675&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2490927075%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3952675&amp;HITNO=13&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3952675&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2490927075%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsRX:</description></item>
<item><title>Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesench</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3919611&amp;HITNO=14&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3919611&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2473559799%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3919611&amp;HITNO=14&amp;MSIZE=42&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanjing%20Clasien%20Pharmaceutical%20%26%20Chemical%20Co.,%20Ltd.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3919611&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2473559799%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>KOTA Territory News:</description></item>
</channel></rss>